220 related articles for article (PubMed ID: 33544929)
41. [Colorectal cancer cells induce the formation of cancer-associated fibroblasts by activating the ERK signaling pathway in fibroblasts].
Deng T; DU B; Xi X
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):943-951. PubMed ID: 37439166
[TBL] [Abstract][Full Text] [Related]
42. Differentiated cancer cell-originated lactate promotes the self-renewal of cancer stem cells in patient-derived colorectal cancer organoids.
Zhao H; Yan C; Hu Y; Mu L; Liu S; Huang K; Li Q; Li X; Tao D; Qin J
Cancer Lett; 2020 Nov; 493():236-244. PubMed ID: 32898601
[TBL] [Abstract][Full Text] [Related]
43. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
44. Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway.
Kim SL; Choi HS; Kim JH; Jeong DK; Kim KS; Lee DS
Oxid Med Cell Longev; 2019; 2019():9296439. PubMed ID: 31019654
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T
Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919
[TBL] [Abstract][Full Text] [Related]
46. Exposure of tumor-associated macrophages to apoptotic MCF-7 cells promotes breast cancer growth and metastasis.
Zhou N; Zhang Y; Zhang X; Lei Z; Hu R; Li H; Mao Y; Wang X; Irwin DM; Niu G; Tan H
Int J Mol Sci; 2015 May; 16(6):11966-82. PubMed ID: 26016502
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
48. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
49. HES1 deficiency impairs development of human intestinal mesenchyme by suppressing WNT5A expression.
Hu J; Li J; Dai C; Ren J; Yang W; He C; Meng F; Dai C; Zeng S
Biochem Biophys Res Commun; 2023 May; 655():50-58. PubMed ID: 36933307
[TBL] [Abstract][Full Text] [Related]
50. Mesenchymal stem cells promote formation of colorectal tumors in mice.
Tsai KS; Yang SH; Lei YP; Tsai CC; Chen HW; Hsu CY; Chen LL; Wang HW; Miller SA; Chiou SH; Hung MC; Hung SC
Gastroenterology; 2011 Sep; 141(3):1046-56. PubMed ID: 21699785
[TBL] [Abstract][Full Text] [Related]
51. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
52. Anti-IL-8 monoclonal antibodies inhibits the autophagic activity and cancer stem cells maintenance within breast cancer tumor microenvironment.
Abou Shousha S; Osman EM; Baheeg S; Shahine Y
Breast Dis; 2024; 43(1):37-49. PubMed ID: 38552109
[TBL] [Abstract][Full Text] [Related]
53. Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts.
Shi J; Feng J; Xie J; Mei Z; Shi T; Wang S; Du Y; Yang G; Wu Y; Cheng X; Li S; Zhu L; Yang CS; Tu S; Jie Z
Sci Rep; 2017 Aug; 7(1):8660. PubMed ID: 28819126
[TBL] [Abstract][Full Text] [Related]
54. The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts.
le Rolle AF; Chiu TK; Fara M; Shia J; Zeng Z; Weiser MR; Paty PB; Chiu VK
J Transl Med; 2015 Jun; 13():199. PubMed ID: 26104296
[TBL] [Abstract][Full Text] [Related]
55. RIP140 regulates transcription factor HES1 oscillatory expression and mitogenic activity in colon cancer cells.
Sfeir N; Kajdan M; Jalaguier S; Bonnet S; Teyssier C; Pyrdziak S; Yuan R; Bousquet E; Maraver A; Bernex F; Pirot N; Boissière-Michot F; Castet-Nicolas A; Lapierre M; Cavaillès V
Mol Oncol; 2024 Jun; 18(6):1510-1530. PubMed ID: 38459621
[TBL] [Abstract][Full Text] [Related]
56. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
57. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
58. H. pylori induces the expression of Hath1 in gastric epithelial cells via interleukin-8/STAT3 phosphorylation while suppressing Hes1.
Zhang X; Yang Y; Zhu R; Bai J; Tian Y; Li X; Peng Z; He Y; Chen L; Fang D; Chen W; Zou Q; Mao X; Wang R
J Cell Biochem; 2012 Dec; 113(12):3740-51. PubMed ID: 22786753
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy.
Kitamura H; Ohno Y; Toyoshima Y; Ohtake J; Homma S; Kawamura H; Takahashi N; Taketomi A
Cancer Sci; 2017 Oct; 108(10):1947-1952. PubMed ID: 28749573
[TBL] [Abstract][Full Text] [Related]
60. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
